Efficacy and Durability of Exenatide in Combination with Pioglitazone vs. Basal-Bolus Insulin in Poorly Controlled Type 2 Diabetic Patients: The QATAR Study

被引：0
|
作者：
Abdul-Ghani, Muhammad
Mujahed, Osama
Mujahed, Ayman
Hassoun, Shai-Maa
Alkasem, Meis
Abou Samra, Abdel Badi
Zirie, Mahmoud
Defronzo, Ralph A.
Jayyousi, Amin
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
188-OR
引用
收藏
页码：A49 / A49
页数：1
相关论文
共 50 条
  • [41] Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Abrahamson, Martin J.
    Peters, Anne
    ANNALS OF MEDICINE, 2012, 44 (08) : 836 - 846
  • [42] Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs When and for whom?
    Mosenzon, Ofri
    Raz, Itamar
    DIABETES CARE, 2013, 36 : S212 - S218
  • [43] DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetic Patients Poorly Controlled with a Basal-Bolus Insulin Regimen
    Franc, Sylvia
    Hanaire, Helene
    Benhamou, Pierre-Yves
    Schaepelynck, Pauline
    Catargi, Bogdan
    Farret, Anne
    Fontaine, Pierre
    Guerci, Bruno
    Reznik, Yves
    Jeandidier, Nathalie
    Penfornis, Alfred
    Borot, Sophie
    Chaillous, Lucy
    Serusclat, Pierre
    Kherbachi, Yacine
    D'Orsay, Genevieve
    Detournay, Bruno
    Simon, Pierre
    Charpentier, Guillaume
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (12) : 904 - 911
  • [44] Fixed-Ratio Insulin Degludec/Liraglutide (IDegLira) vs. Basal-Bolus Treatment in Type 2 Diabetic (T2DM) Patients with Diabetic Foot Ulcers (DFU) and Critical Limb Ischemia (CLI)
    Falcetta, Pierpaolo
    Indovina, Francesco S.
    Giannarelli, Rosa
    Piaggesi, Alberto
    Penno, Giuseppe
    Miccoli, Roberto
    Del Prato, Stefano
    Coppelli, Alberto
    DIABETES, 2019, 68
  • [45] Stepwise intensification of prandial insulin versus basal-bolus insulin therapy in patients with type 2 diabetes mellitus
    Raccah, D.
    Haak, T.
    Huet, D.
    Monnier, L.
    Ramon, J. S.
    Robertson, D.
    Labard, P.
    Penfornis, A.
    DIABETOLOGIA, 2010, 53
  • [46] Initiation of iGlarLixi vs. Basal-Bolus Insulin (BB) in Adults with Type 2 Diabetes (T2D) Advancing from Basal Insulin (BI) Therapy: The SoliComplex Real-World Study
    Pantalone, Kevin M.
    Heller, Caroline
    Lajara, Rosemarie
    Lew, Elisheva
    Li, Xuan
    Dex, Terry A.
    Kilpatrick, Rachel
    DIABETES, 2022, 71
  • [47] BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA
    Bueno, Elvio
    Benitez, Aldo
    Vera Rufinelli, Jazmin
    Figueredo, Rafael
    Alsina, Shirley
    Ojeda, Aldo
    Samudio, Sandra
    Caceres, Mirta
    Arguello, Rocio
    Romero, Fabiola
    Echague, Gloria
    Pasquel, Francisco
    Umpierrez, Guillermo E.
    ENDOCRINE PRACTICE, 2015, 21 (07) : 807 - 813
  • [48] Safety and efficacy of insulin aspart vs. regular human insulin in basal/bolus therapy for patients with gestational diabetes
    Jovanovic, L
    Howard, C
    Pettitt, D
    Zisser, H
    Ospina, P
    DIABETES, 2005, 54 : A675 - A675
  • [49] Glycemic control with a basal-bolus insulin protocol in hospitalized diabetic patients treated with glucocorticoids: a retrospective cohort study
    Elena Chertok Shacham
    Hila Kfir
    Naama Schwartz
    Avraham Ishay
    BMC Endocrine Disorders, 18
  • [50] Real life effectiveness of initiation of basal insulin in type 2 insulin naive diabetic patients: Giargine vs. Nph vs. detemir
    Sharplin, Peter
    Mehin, Nazanin
    Mcewan, Phil
    Tetlow, Tony
    DIABETES, 2007, 56 : A658 - A659
12345